BFM
KRRO icon

Boothbay Fund Management’s Korro Bio KRRO Stock Holding History

Boothbay Fund Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed -$310K – 1669
2020
Q4 		$310K Buy
+2
New +$2.64K 0.01% 936

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Boothbay Fund Management's KRRO Position: Q2 2026 in Review

Boothbay Fund Management reduced its Korro Bio (KRRO) stake by 15% in Q2 2026, selling an estimated $76.4K and leaving 35,853 shares worth $473K. The position accounts for 0.01% of the portfolio, ranked #1536.

Boothbay Fund Management first reported a position in KRRO in Q4 2020 and has held it in 3 quarters since. The position peaked at $475K in Q1 2026. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Boothbay Fund Management held 35,853 shares of Korro Bio worth $473K as of Q2 2026.
  • Boothbay Fund Management sold 6,147 Korro Bio shares in Q2 2026, an estimated $76.4K.
  • Korro Bio made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1536 holding.
  • Boothbay Fund Management first reported a position in Korro Bio in Q4 2020 and has held it in 3 quarters since.
  • Boothbay Fund Management's Korro Bio position peaked at $475K in Q1 2026.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.